Investor Relations

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.


All Releases
View Summary PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
Mar 6, 2014
PDF 14.8 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO PRESENT AT THE COWEN & COMPANY 34TH ANNUAL HEALTH CARE CONFERENCE
Feb 28, 2014
PDF 6.5 KB Add to Briefcase
View Summary PTC THERAPEUTICS REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635 (c )(4)
Feb 27, 2014
PDF 6.9 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO HOST FOURTH QUARTER AND YEAR END 2013 FINANCIAL RESULTS CONFERENCE CALL
Feb 27, 2014
PDF 6.6 KB Add to Briefcase
View Summary PTC THERAPEUTICS EXPANDS INTERNATIONAL COMMERCIAL TEAM
Feb 25, 2014
PDF 8.7 KB Add to Briefcase
View Summary PTC Therapeutics to Present at Upcoming Investor Conferences
Feb 20, 2014
PDF 6.9 KB Add to Briefcase
View Summary PTC Therapeutics Announces Closing of Registered Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Feb 19, 2014
PDF 7.1 KB Add to Briefcase
View Summary PTC THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
Feb 12, 2014
PDF 7.7 KB Add to Briefcase
View Summary PTC Therapeutics Announces Proposed Public Offering of Common Stock
Feb 10, 2014
PDF 7.2 KB Add to Briefcase
View Summary PTC Therapeutics Announces that Stuart W. Peltz, Ph.D., CEO is the Recipient of the 2014 Dr. Sol J. Barer Award for Vision, Innovation and Leadership
Jan 30, 2014
PDF 7.6 KB Add to Briefcase
View Summary PTC THERAPEUTICS PROVIDES UPDATE ON CHMP OPINION FOR CONDITIONAL APPROVAL OF ATALUREN FOR NONSENSE MUTATION DUCHENNE MUSCULAR DYSTROPHY
Jan 24, 2014
PDF 13.6 KB Add to Briefcase
View Summary PTC THERAPEUTICS EXPANDS MANAGEMENT TEAM
Jan 24, 2014
PDF 10.8 KB Add to Briefcase
View Summary JOINT PROGRAM IN SPINAL MUSCULAR ATROPHY ENTERS FIRST STAGE OF CLINICAL DEVELOPMENT
Jan 22, 2014
PDF 9.8 KB Add to Briefcase
View Summary PTC Therapeutics to Present at the J.P. Morgan Healthcare Conference
Jan 6, 2014
PDF 7.4 KB Add to Briefcase
View Summary PTC THERAPEUTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX
Dec 23, 2013
PDF 7.7 KB Add to Briefcase
View Summary ATALUREN CLINICAL DATA DEMONSTRATE AN INCREASE IN DYSTROPHIN EXPRESSION IN DUCHENNE MUSCULAR DYSTROPHY PATIENTS
Dec 12, 2013
PDF 10.8 KB Add to Briefcase
View Summary PTC THERAPEUTICS REPORTS THIRD QUARTER 2013 FINANCIAL AND CORPORATE RESULTS
Nov 14, 2013
PDF 275.7 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO HOST THIRD QUARTER 2013 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST
Nov 7, 2013
PDF 7.8 KB Add to Briefcase
View Summary PTC THERAPEUTICS TO PRESENT AT CREDIT SUISSE ANNUAL HEALTH CARE CONFERENCE
Nov 5, 2013
PDF 7.6 KB Add to Briefcase
View Summary PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
Oct 18, 2013
PDF 7.6 KB Add to Briefcase
Showing 1-20 of 57 Page: 1 2 3  Next 20
Add to Briefcase = add release to Briefcase